Factor | Renal Transplant recipients | Missing, N (%) |
---|---|---|
N with valid Followup times | ||
Male Recipient (female) | 23,827 (60.1) | 0 |
African American (all other races) | 9142 (23.1) | 640 (1.5) |
Graft lossB (Absent) | 2815 (6.5%) | 0 |
Cadaveric Donor (living donor) | 27,369 (69.1) | 0 |
Quartiles of Age (vs. >55 years) | ||
<33 | ||
33–44 | ||
45–55 | ||
Diabetes as a comorbidity at listing (vs. absent) | 7977 (24.7) | 9931 (23.3) |
History of Peritoneal Dialysis (vs. Hemodialysis) | 8260 (19.6) | 7855 (18.7) |
Recipient HCV Positive (Yes/No) | 2198 (5.6) | 5743 (13.6) |
Donor CMV Positive (Yes/No) | 23,552 (57.1) | 1620 (3.8) |
Pretransplant dialysis (Yes/No) | 31,046 (86) | 284 (0.8) |
Rejection (Yes/No) | 8335 (19.8) | 0 |
Cause of ESRD (vs. all others) | ||
Diabetes | 7862 (19.7) | 5178 (12.3%) |
Hypertension | 5495 (13.2) | 5178 (12.3%) |
Maintenance Medications | ||
Cyclosporine (vs. Tacrolimus) | 31,448 (74.7) | 3372 (8) |
Tacrolimus (vs. Cyclosporine) | 4623 (11.9) | 3372 (8) |
Mycophenolate (vs. Azathioprine) | 18,608 (47.9) | 3221 (7.6) |
Azathioprine (vs. Mycophenolate) | 16,308 (41.9) | 3157 (7.5) |
Prednisone (vs. all others) | 34,451 (90.1) | 3880 (9.2) |
Induction Antibody Therapy | 11,905 (28.3) | 2277 (5.4) |
Employment Status | ||
Working Full time | 14,714 | |
Working Part time by choice | 858 | |
Working Part time due to disease | 2012 | |
Working part time reason unknown | 200 | |
Not working | 13,833 | |
Retired | 2940 | |
Missing or unknown | 7539 |